Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 1–50 of 38,222 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003641	High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma	completed	Phase 3	1,150	ECOG-ACRIN Cancer Research GroupNETWORK	4	Sep 29, 2026	clinicaltrials
NCT00421213	Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers	completed	Phase 2	50	Alaunos TherapeuticsINDUSTRY	1	Sep 29, 2026	clinicaltrials